Surrey researchers Sign in
EN2: A Novel Immunotherapeutic Target for Melanoma
Conference presentation   Peer reviewed

EN2: A Novel Immunotherapeutic Target for Melanoma

NE Annels, C Riley, S Bokaee, M Denyer, GR Simpson and H Pandha
J IMMUNOTHER, Vol.33(8), pp.891-891
10/2010

Abstract

Details

Usage Policy